Papers
6
Total Citations
165
H-Index
6
About
Dr. N. Grenier is a leading urologic oncologist whose research focuses on advancing minimally invasive treatments for renal tumors, particularly through the integration of cutting-edge imaging and robotic technologies. A central theme of their work is the comparative effectiveness of partial nephrectomy and percutaneous tumor ablation for renal cell carcinoma. Their landmark 2021 multi-institutional study on 3D-image guided robotic-assisted partial nephrectomy (73 citations) established a new standard for precision surgery, demonstrating superior outcomes through advanced visualization. Dr. Grenier’s 2016 work on imperative-setting treatments (42 citations) provided critical guidance for high-risk patients, while their recent AblatT1b study (25 citations) offers the first robust matched-pair comparison of ablation versus robotic surgery for T1b tumors. Pioneering the use of machine learning, they developed a CT-based radiomic model (11 citations) that significantly improves preoperative prediction of tumor malignancy, potentially sparing patients unnecessary surgery. Their 2022 salvage robotic nephrectomy study (6 citations) addresses a critical gap in managing ablation failures. As a key investigator in the UroCCR network, Dr. Grenier’s work consistently shapes clinical decision-making, balancing oncologic efficacy with renal function preservation.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6